FOLH1 Antibody - N-terminal region

Aviva Systems Biology

FOLH1 Antibody - N-terminal region

23

WB: 1:1000 IHC-P: 1:10~50 IF: 1:10~50

ImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

0.5 mg/ml

Liquid. PBS with 0.09% (W/V) sodium azide.

FOLH1

folate hydrolase 1

FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM, PSMA, mGCP, glutamate carboxypeptidase 2, N-acetylated alpha-linked acidic dipeptidase 1, N-acetylated-alpha-linked acidic dipeptidase I, NAALADase I, cell growth-inhibiting gene 27 protein, folylpoly-gamma-glutamate carboxypeptidase, glutamate carboxylase II, glutamate carboxypeptidase II, membrane glutamate carboxypeptidase, pteroylpoly-gamma-glutamate carboxypeptidase

Rabbit

Glutamate carboxypeptidase 2

This gene encodes a type II transmembrane glycoprotein belonging to the M28 peptidase family. The protein acts as a glutamate carboxypeptidase on different alternative substrates, including the nutrient folate and the neuropeptide N-acetyl-l-aspartyl-l-glutamate and is expressed in a number of tissues such as prostate, central and peripheral nervous system and kidney. A mutation in this gene may be associated with impaired intestinal absorption of dietary folates, resulting in low blood folate levels and consequent hyperhomocysteinemia. Expression of this protein in the brain may be involved in a number of pathological conditions associated with glutamate excitotoxicity. In the prostate the protein is up-regulated in cancerous cells and is used as an effective diagnostic and prognostic indicator of prostate cancer. This gene likely arose from a duplication event of a nearby chromosomal region. Alternative splicing gives rise to multiple transcript variants encoding several different isoforms.

Human

-20°C,2°C to 8°C

41116161